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A good sugar, d‑mannose, suppresses
autoimmune diabetes
Yun‑Bo Shi1*

and Deling Yin2

Abstract
It is well known that too much sugar uptake causes many health problems, including diabetes and obesity (Lustig
et al. in Nature 482:27–29, 2012). However, a team of researchers led by Dr. Wanjun Chen of the National Institute of
Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), USA, have recently shown that d-man‑
nose, a naturally occurring C-2 epimer of glucose is likely beneficial to human health. Their studies have revealed that
supraphysiological levels of d-mannose that are safely achievable via drinking-water supplementation can be preven‑
tive and therapeutic to experimental autoimmune diabetes and asthmatic lung inflammation (Zhang et al. in Nat
Med 23:1036–1045, 2017).
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With the improvement of the living standard in the
world, the incidence of many health problems has significantly increased over the past few decades. Among them
include autoimmune diseases, obesity, diabetes, cardiovascular and cerebrovascular diseases, allergy/asthma,
and cancer. In addition to the genetic and environmental
factors, diet has long been postulated as a potential risk
factor for the emerging and increase of many of aforementioned diseases in the world, especially in the developed countries. One dietary factor, which has rapidly
changed along with the western diet and increased consumption of processed food, is sugar [1]. Eating too much
sugar raises the risk for health problems that are associated with obesity, diabetes, cardiovascular diseases, and
autoimmune diseases, etc. This has led to a logical and
popular advice of restriction of sugar uptake.
This notion is not without exception, at least for
d-mannose, a monosaccharide and C-2 epimer of glucose, based on new findings from a team of investigators led by Dr. Wanjun Chen of NIH, USA, including
his collaborators from China. They have discovered that
d-mannose can surprisingly prevent and suppress type
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1 autoimmune diabetes and asthmatic lung inflammation [2]. They showed that oral administration of supraphysiological amounts of d-mannose in drinking
water of non-obese diabetic (NOD) mice before they
developed hyperglycemia could prevent diabetes development in those mice. Strikingly, they also found that
oral administration of d-mannose was able to block
the progress of diabetes even in NOD mice with newonset diabetes. Importantly, they also revealed that this
d-mannose-mediated suppression of inflammation is not
unique in autoimmune diabetes since oral administration of d-mannose also prevented and suppressed airway inflammation in the lungs in an ovalbumin-induced
asthmatic lung airway inflammation model. Mechanistically, Dr. Chen and his colleagues have demonstrated
that d-mannose induces the generation of regulatory T
cell (Treg) from naïve CD4+ CD25− T cells. Treg cells are
essential immunoregulatory cells that are instrumental
in the induction and maintenance of immune tolerance
and in the prevention and suppression of inflammation
and autoimmune diseases. They have further revealed
that the d-mannose-mediated generation of Treg cells is
accomplished by the activation of transforming growth
factor beta (TGF-β), one of the most important immunosuppressive cytokines [3]. The activation of TGF-β
in T cells by d-mannose is attributable to at least two
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independent yet complementary pathways, integrin αvβ8
and reactive oxygen species (ROS) pathways.
These novel findings led the authors to consider their
potential clinical implications and the possibility and barriers to overcome in order to translate them into clinical
use toward human diseases. While the physiological level
of d-mannose in human and mouse blood is relative low
(~ 100 μM, 1/50 of the glucose level), it has been reported
that it could be increased up to nine-fold in mice with
no adverse consequences after long-term d-mannose
oral administration [4]. More importantly, stable serum
d-mannose levels of up to 2 mM can be reached and
are well tolerated in humans without any sign of liver
or renal toxicity [5]. More importantly, Dr. Chen and
his colleagues showed that in vitro as low as 1 mM of
d-mannose was able to induce Treg cell formation from
naive CD4+ T cells. Furthermore, d-mannose has already
been used for human disease treatment, includes congenital disorders of glycosylation type Ib [6] and bacterial urinary tract infection [7]. All these suggest that the
supraphysiological levels of d-mannose in human can be
reached by administration of d-mannose for disease prevention and treatment without adverse effect on human.
In sum, the studies by Dr. Chen and his colleagues have
discovered that d-mannose is a “healthy/good” monosaccharide and suggest that this unique sugar could be a safe
dietary supplement to promote immune tolerance and
to treat/prevent human diseases associated with autoimmunity and allergy.
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